Cordatus Wealth Management LLC Acquires 204 Shares of UnitedHealth Group Incorporated (NYSE:UNH)

Cordatus Wealth Management LLC increased its holdings in UnitedHealth Group Incorporated (NYSE:UNH) by 2.0% during the 4th quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund owned 10,235 shares of the healthcare conglomerate’s stock after purchasing an additional 204 shares during the quarter. UnitedHealth Group makes up 1.4% of Cordatus Wealth Management LLC’s investment portfolio, making the stock its 17th biggest holding. Cordatus Wealth Management LLC’s holdings in UnitedHealth Group were worth $5,177,000 as of its most recent SEC filing.

Other large investors have also bought and sold shares of the company. AlphaMark Advisors LLC bought a new position in shares of UnitedHealth Group during the fourth quarter worth about $30,000. RPg Family Wealth Advisory LLC bought a new position in UnitedHealth Group during the 3rd quarter worth approximately $37,000. DecisionPoint Financial LLC boosted its stake in shares of UnitedHealth Group by 155.0% in the 4th quarter. DecisionPoint Financial LLC now owns 102 shares of the healthcare conglomerate’s stock valued at $52,000 after purchasing an additional 62 shares during the last quarter. Highline Wealth Partners LLC bought a new position in UnitedHealth Group during the third quarter worth $55,000. Finally, Legacy Investment Solutions LLC bought a new stake in UnitedHealth Group during the third quarter valued at $57,000. 87.86% of the stock is owned by institutional investors.

Insiders Place Their Bets

In other news, Director Timothy Patrick Flynn bought 1,000 shares of the firm’s stock in a transaction on Friday, January 17th. The stock was acquired at an average cost of $511.57 per share, with a total value of $511,570.00. Following the completion of the transaction, the director now directly owns 4,500 shares of the company’s stock, valued at $2,302,065. This represents a 28.57 % increase in their position. The transaction was disclosed in a legal filing with the SEC, which is accessible through this link. Insiders own 0.33% of the company’s stock.

Analysts Set New Price Targets

A number of brokerages have recently issued reports on UNH. Deutsche Bank Aktiengesellschaft boosted their price objective on UnitedHealth Group from $595.00 to $625.00 and gave the company a “buy” rating in a research note on Tuesday, December 3rd. KeyCorp restated an “overweight” rating and set a $650.00 price target on shares of UnitedHealth Group in a report on Friday, January 17th. HSBC upgraded shares of UnitedHealth Group from a “hold” rating to a “buy” rating and set a $595.00 target price on the stock in a research report on Friday, January 10th. Truist Financial reduced their target price on UnitedHealth Group from $625.00 to $610.00 and set a “buy” rating for the company in a research note on Monday, January 6th. Finally, Hsbc Global Res upgraded UnitedHealth Group from a “hold” rating to a “strong-buy” rating in a report on Friday, January 10th. One investment analyst has rated the stock with a hold rating, twenty have given a buy rating and two have given a strong buy rating to the company. According to MarketBeat.com, the company currently has an average rating of “Buy” and a consensus price target of $629.32.

UnitedHealth Group Trading Down 1.6 %

NYSE:UNH opened at $503.01 on Friday. UnitedHealth Group Incorporated has a 52 week low of $436.38 and a 52 week high of $630.73. The firm has a 50-day moving average price of $520.37 and a two-hundred day moving average price of $561.26. The firm has a market cap of $462.91 billion, a price-to-earnings ratio of 32.45, a price-to-earnings-growth ratio of 1.40 and a beta of 0.61. The company has a debt-to-equity ratio of 0.74, a quick ratio of 0.91 and a current ratio of 0.83.

UnitedHealth Group (NYSE:UNH) last posted its quarterly earnings data on Thursday, January 16th. The healthcare conglomerate reported $6.81 earnings per share for the quarter, topping the consensus estimate of $6.74 by $0.07. The business had revenue of $100.81 billion for the quarter, compared to analysts’ expectations of $101.60 billion. UnitedHealth Group had a return on equity of 26.69% and a net margin of 3.60%. The business’s revenue was up 6.8% on a year-over-year basis. During the same quarter in the previous year, the firm earned $5.83 earnings per share. On average, equities analysts expect that UnitedHealth Group Incorporated will post 29.54 earnings per share for the current fiscal year.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.